Blackmores vitamins and supplements bolster HY results

Company News

by Jessica Ellerm

Blackmores (ASX:BKL) etched a 20 per cent rise in its net profit after tax to $34 million in the half year ending December (when compared to the same time last year).

Revenue rose over 9 per cent to $287 million with a strong lift in BioCeuticals (vitamins and supplements), Chinese and Asian market sales.

Meantime its earnings (EBIT) lifted 19 per cent on the prior corresponding period (pcp) to $26 million.

Its half year dividend is 15 per cent higher than the pcp and at $1.50 per share, fully franked.

Shares in Blackmores are trading 14.11 per cent lower at $137.

Jessica Ellerm

Finance News Network
Jessica joined FNN in April 2016 and presents the Australian Share Market Outlook, and reports on the morning's leading business stories. Alongside FNN Jessica is a fintech industry commentator, writing for her own blog and a number of international online publications.